Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$927M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$430M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$382M |
| 5 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
+$306M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$507M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$430M |
| 4 |
iShares Russell Mid-Cap ETF
IWR
|
+$356M |
| 5 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.75% |
| 2 | Healthcare | 8.81% |
| 3 | Financials | 8.45% |
| 4 | Consumer Discretionary | 7.56% |
| 5 | Industrials | 7.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4401
Star Group
SGU
$415M
| $588K | ﹤0.01% |
57,669
-2,500
| -4% | -$27.1K |
|
|
AOMR
4402
Angel Oak Mortgage REIT
AOMR
$208M
| $587K | ﹤0.01% |
34,597
+33,498
| +3,048% | +$595K |
|
4403
Clover Health Investments
CLOV
$2.33B
| $585K | ﹤0.01% |
79,237
+10,964
| +16% | +$93.8K |
|
4404
Gevo
GEVO
$403M
| $585K | ﹤0.01% |
88,036
-10,634
| -11% | -$65.8K |
|
|
ALPN
4405
DELISTED
Alpine Immune Sciences Inc
ALPN
| $585K | ﹤0.01% |
54,878
+54,578
| +18,193% | +$503K |
|
4406
Accuray
ARAY
$34.6M
| $584K | ﹤0.01% |
147,859
-367,742
| -71% | -$1.46M |
|
|
FLIC
4407
DELISTED
First of Long Island Corp
FLIC
| $584K | ﹤0.01% |
28,361
+18,626
| +191% | +$391K |
|
4408
Shattuck Labs
STTK
$686M
| $584K | ﹤0.01% |
28,692
+28,513
| +15,929% | +$610K |
|
4409
JPMorgan BetaBuilders Europe ETF
BBEU
$9.52B
| $583K | ﹤0.01% |
10,207
+5,158
| +102% | +$307K |
|
|
ENX
4410
DELISTED
Eaton Vance New York Municipal Bond Fund
ENX
| $582K | ﹤0.01% |
47,471
-4,876
| -9% | -$61.5K |
|
|
BRW
4411
Saba Capital Income & Opportunities Fund
BRW
$336M
| $581K | ﹤0.01% |
63,808
-39,615
| -38% | -$364K |
|
4412
Cartesian Therapeutics
RNAC
$260M
| $581K | ﹤0.01% |
4,660
+2,832
| +155% | +$342K |
|
4413
VanEck Israel ETF
ISRA
$159M
| $577K | ﹤0.01% |
12,227
+269
| +2% | +$12.8K |
|
4414
German American Bancorp
GABC
$1.89B
| $576K | ﹤0.01% |
14,883
-8,897
| -37% | -$331K |
|
|
VINC
4415
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $576K | ﹤0.01% |
1,782
+1,457
| +448% | +$425K |
|
|
GOEV
4416
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $575K | ﹤0.01% |
163
+127
| +353% | +$453K |
|
|
IMPL
4417
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $574K | ﹤0.01% |
+47,146
| New | +$684K |
|
4418
CALL
Takeda Pharmaceutical
TAK
$55.8B
| $573K | ﹤0.01% |
35,000
-2,000
| -5% | -$33.6K |
|
4419
ANI Pharmaceuticals
ANIP
$1.71B
| $571K | ﹤0.01% |
17,404
-3,865
| -18% | -$120K |
|
4420
Cognyte Software
CGNT
$692M
| $571K | ﹤0.01% |
27,742
+6,803
| +32% | +$174K |
|
4421
CALL
Ternium
TX
$10.7B
| $571K | ﹤0.01% |
13,500
| – | – |
|
4422
PureCycle Technologies
PCT
$1.54B
| $569K | ﹤0.01% |
42,791
+2,210
| +5% | +$33.3K |
|
4423
Butterfly Network
BFLY
$2.5B
| $568K | ﹤0.01% |
54,452
+22,226
| +69% | +$257K |
|
4424
TherapeuticsMD
TXMD
$24M
| $568K | ﹤0.01% |
15,296
+9,575
| +167% | +$425K |
|
4425
CALL
Advanced Micro Devices
AMD
$774B
| $566K | ﹤0.01% |
5,500
-90,000
| -94% | -$9.2M |
|
Similar funds
Wells Fargo's Q3 2021 Portfolio in Review
As of Q3 2021, Wells Fargo held 8,005 positions worth $455B, down 0.26% from $456B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Wells Fargo's Q3 2021 filing shows 478 new, 3,039 increased, 3,074 reduced and 321 closed positions. Its largest new stake was Blend Labs: 6,286,123 shares worth $84.7M. The largest sale was iShares Russell 2000 ETF, an estimated $1.03B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- Wells Fargo's largest Q3 2021 buy was Blend Labs: 6,286,123 shares worth $84.7M.
- Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $1.04B increase.
- Wells Fargo's biggest Q3 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $1.03B.
- Wells Fargo fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $166M.
- Wells Fargo's ten largest holdings make up 16% of its $455B portfolio in Q3 2021.
- Wells Fargo opened 478 new positions and closed 321 in Q3 2021.
- Wells Fargo's portfolio value fell 0.26% quarter-over-quarter to $455B.
Based on Wells Fargo's 13F filing for Q3 2021, filed 15 Nov 2021.